Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease

NCT01998802 is registered in ClinicalTrials.gov with Eleven Biotherapeutics as lead sponsor.

NCT NCT01998802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01998802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Contraol In Subjects With Moderate to Severe Dry Eye Disease
Lead sponsor
Eleven Biotherapeutics
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
April 30, 2015
Enrollment
670 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)